Filing Flows › Iridex (IRIX) › Q2 2025
Iridex (IRIX) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 12, 2025
Iridex (IRIX) reported revenue of $13.6M for the second quarter 2025 (Q2 2025), +7% from a year earlier and +14% from the quarter before. Operating margin was -6.9%, net loss $994K (7.3% of revenue).
Iridex, Q2 2025: revenue $13.6M (+7% year over year), operating margin -6.9%, net loss $994K, operating cash flow −$397K. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.6M | +14% | +7% |
| Operating profit | −$940K | — | — |
| Net earnings | −$994K | — | — |
| Operating cash flow | −$397K | — | — |
What changed
Revenue was $13.6M in Q2 2025, up 7% year over year and up 14% from the previous quarter. Retina was the largest line at 59% of revenue. Retina added $752K year over year (up 10%), 80% of the total change. Cyclo G Six declined 1%.
Gross margin was 34.5%, down 6.2 points from a year earlier. Operating costs exceeded revenue by $940K, an operating margin of -6.9%. Operating expenses fell 28% while revenue rose 7%. The quarter ended with a net loss of $1.0M, narrower than the previous quarter's $1.7M loss.
Operating cash flow was −$397K. Non-cash charges added back $127K of depreciation and amortization and $257K of share-based compensation. Working capital and other items added $213K. Capital expenditures of $13K exceeded it, leaving free cash flow of −$410K.
Questions
What was Iridex's revenue in the second quarter 2025?
Iridex (IRIX) reported revenue of $13.6M for the second quarter 2025 (Q2 2025), +7% from a year earlier and +14% from the quarter before.
Was Iridex profitable in the second quarter 2025?
Operating loss was $940K (-6.9% of revenue) and net loss $994K.
Source: Iridex 10-Q on SEC EDGAR.